Mitchell Dowsett

Pharmacology of novel steroidal inhibitors of cytochrome P45017α (17α-hydroxylase/C17–20 lyase)

B. Haynes, M. Jarman, P. Goddard, 1994, The Journal of Steroid Biochemistry and Molecular Biology.

Biochemistry and pharmacokinetics of potent non-steroidal cytochrome P45017α inhibitors

M. Dowsett, B. Haynes, M. Jarman, 1997, The Journal of Steroid Biochemistry and Molecular Biology.

Idoxifene: report of a phase I study in patients with metastatic breast cancer.

M. Dowsett, R. Coombes, I. Judson, 1995, Cancer research.

Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer.

E. Perez, M. Dowsett, J. Ingle, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.

T. Powles, M. Dowsett, R. Coombes, 1986, Cancer research.

Pyrrolidino-4-iodotamoxifen and 4-iodotamoxifen, new analogues of the antiestrogen tamoxifen for the treatment of breast cancer.

M. Dowsett, R. Coombes, Y. Luqmani, 1991, Cancer research.